Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin

R. Safirstein, M. Daye, Joseph Guttenplan

Research output: Contribution to journalArticle

Abstract

Cisplatin and its biotransformation products were analyzed in human and rat urine and in plasma from rats. Analyses were performed using high performance liquid chromatography (HPLC). Microbial mutagenesis assays were performed on effluents from the chromatographic system. After intravenous administration to man (50 mg/m2) and intravenous and intraperitoneal administration to rats (5-10 mg/kg), platinum was excreted in the urine in a form that co-eluted mainly with cisplatin. Unbound drug in the plasma co-eluted with cisplatin. Furthermore excreted platinum exhibited mutagenic and chemical reactivity similar to that of cisplatin. We conclude that the principal form of free platinum circulating in blood and excreted in urine is cisplatin.

Original languageEnglish (US)
Pages (from-to)329-338
Number of pages10
JournalCancer Letters
Volume18
Issue number3
DOIs
StatePublished - 1983

Fingerprint

Platinum
Cisplatin
Urine
Intravenous Administration
Biotransformation
Mutagenesis
High Pressure Liquid Chromatography
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin. / Safirstein, R.; Daye, M.; Guttenplan, Joseph.

In: Cancer Letters, Vol. 18, No. 3, 1983, p. 329-338.

Research output: Contribution to journalArticle

@article{20bf7dea89904ad6af3d93429e05152a,
title = "Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin",
abstract = "Cisplatin and its biotransformation products were analyzed in human and rat urine and in plasma from rats. Analyses were performed using high performance liquid chromatography (HPLC). Microbial mutagenesis assays were performed on effluents from the chromatographic system. After intravenous administration to man (50 mg/m2) and intravenous and intraperitoneal administration to rats (5-10 mg/kg), platinum was excreted in the urine in a form that co-eluted mainly with cisplatin. Unbound drug in the plasma co-eluted with cisplatin. Furthermore excreted platinum exhibited mutagenic and chemical reactivity similar to that of cisplatin. We conclude that the principal form of free platinum circulating in blood and excreted in urine is cisplatin.",
author = "R. Safirstein and M. Daye and Joseph Guttenplan",
year = "1983",
doi = "10.1016/0304-3835(83)90244-6",
language = "English (US)",
volume = "18",
pages = "329--338",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin

AU - Safirstein, R.

AU - Daye, M.

AU - Guttenplan, Joseph

PY - 1983

Y1 - 1983

N2 - Cisplatin and its biotransformation products were analyzed in human and rat urine and in plasma from rats. Analyses were performed using high performance liquid chromatography (HPLC). Microbial mutagenesis assays were performed on effluents from the chromatographic system. After intravenous administration to man (50 mg/m2) and intravenous and intraperitoneal administration to rats (5-10 mg/kg), platinum was excreted in the urine in a form that co-eluted mainly with cisplatin. Unbound drug in the plasma co-eluted with cisplatin. Furthermore excreted platinum exhibited mutagenic and chemical reactivity similar to that of cisplatin. We conclude that the principal form of free platinum circulating in blood and excreted in urine is cisplatin.

AB - Cisplatin and its biotransformation products were analyzed in human and rat urine and in plasma from rats. Analyses were performed using high performance liquid chromatography (HPLC). Microbial mutagenesis assays were performed on effluents from the chromatographic system. After intravenous administration to man (50 mg/m2) and intravenous and intraperitoneal administration to rats (5-10 mg/kg), platinum was excreted in the urine in a form that co-eluted mainly with cisplatin. Unbound drug in the plasma co-eluted with cisplatin. Furthermore excreted platinum exhibited mutagenic and chemical reactivity similar to that of cisplatin. We conclude that the principal form of free platinum circulating in blood and excreted in urine is cisplatin.

UR - http://www.scopus.com/inward/record.url?scp=0020527303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020527303&partnerID=8YFLogxK

U2 - 10.1016/0304-3835(83)90244-6

DO - 10.1016/0304-3835(83)90244-6

M3 - Article

VL - 18

SP - 329

EP - 338

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 3

ER -